Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3765814
Max Phase: Preclinical
Molecular Formula: C16H29NO4
Molecular Weight: 299.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3765814
Max Phase: Preclinical
Molecular Formula: C16H29NO4
Molecular Weight: 299.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCC[C@@H](O)[C@H](C)C(=O)N1C(=O)OC[C@@H]1C(C)C
Standard InChI: InChI=1S/C16H29NO4/c1-5-6-7-8-9-14(18)12(4)15(19)17-13(11(2)3)10-21-16(17)20/h11-14,18H,5-10H2,1-4H3/t12-,13+,14+/m0/s1
Standard InChI Key: SUIILUXKRPDZRE-BFHYXJOUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 299.41 | Molecular Weight (Monoisotopic): 299.2097 | AlogP: 2.96 | #Rotatable Bonds: 8 |
Polar Surface Area: 66.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.61 | CX LogD: 3.61 |
Aromatic Rings: 0 | Heavy Atoms: 21 | QED Weighted: 0.70 | Np Likeness Score: 0.89 |
1. Singh S, Gajulapati V, Gajulapati K, Goo JI, Park YH, Jung HY, Lee SY, Choi JH, Kim YK, Lee K, Heo TH, Choi Y.. (2016) Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers., 26 (4): [PMID:26810262] [10.1016/j.bmcl.2016.01.016] |
Source(1):